NEC OncoImmunity AS

NEC OncoImmunity is a Norwegian biotechnology company aiming to develop innovative treatments against incurable cancers and infectious disease.

Design & Develop New Biotech Website

SiteCenter were delighted to be selected as the winning bidder to create a new biotechnology website for OncoImmunity AS. Our brief included developing brand assets for this early stage start-up, as well as full website design and development. As part of our solution, we created a fully bespoke secure dashboard with a Content Management System (CMS) to give the client full control over the website's content.

We were behind OncoImmunity's web strategy for over five years - from tech discovery to acquisition by NEC in 2019.

  • Design & Develop New Biotech Website
  • Design & Develop New Biotech Website
  • Design & Develop New Biotech Website
Want news and insights from SiteCenter?
Send me your newsletter about industry trends plus news of SiteCenter products and services.
You can unsubscribe at any time, and we promise to never share your email address - read our Privacy Policy.
© Copyright SiteCenter.com 2026. All rights reserved. All other trademarks and copyrights are property of their respective owners.